Onconetix, Inc.
Onconetix, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B Convertible Redeemable Preferred Stock | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | |||||
Assets | |||||||||||||||||
Series C Redeemable Preferred Stock | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | |||||
Related Party | - | - | - | - | - | - | - | -3 | 0 | 5 | - | - | |||||
Series C Convertible Redeemable Preferred Stock | - | - | - | - | - | - | 0 | - | - | - | 0 | - | |||||
Series D Preferred Stock | - | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | |||||
Series A Convertible Preferred Stock | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | - | - | - | - | - | - | - | - | - | 0 | - | 0 | |||||
Series E Preferred Stock | - | 0 | 0 | - | - | - | 0 | - | - | - | - | - | |||||
Assets Current | |||||||||||||||||
Cash | 6 | 4 | 5 | 1 | 0 | 2 | 1 | - | - | 4 | 5 | 8 | |||||
Cash And Cash Equivalents At Carrying Value | - | - | 5 | - | - | - | 1 | 0 | 1 | - | 5 | 8 | |||||
Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Other Receivables Net Current | - | - | 0 | - | - | - | -0 | - | - | - | - | - | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | |||||
Assets Current | 7 | 4 | 6 | 1 | 1 | 2 | 1 | 1 | 2 | 6 | 6 | 10 | |||||
Prepaid Expense Noncurrent | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Deferred Costs | 0 | 0 | 0 | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Intangible Assets Net Excluding Goodwill | - | - | - | - | - | - | - | 21 | 20 | 21 | 25 | 18 | |||||
Goodwill | 10 | 10 | 19 | 18 | 18 | 16 | 27 | 39 | 37 | 47 | 56 | - | |||||
Assets | 16 | 15 | 25 | 20 | 19 | 19 | 28 | 62 | 59 | 75 | 88 | 28 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Convertible Notes Payable Current | - | - | - | - | - | - | - | - | - | - | - | 13 | |||||
Accounts Payable Current | 2 | 2 | 2 | 2 | 3 | 3 | 4 | 4 | 3 | 4 | 5 | 3 | |||||
Accrued Liabilities Current | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | |||||
Notes Payable Current | 0 | 0 | - | 0 | 9 | 9 | 9 | - | 10 | 10 | 10 | - | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Other Notes Payable Current | - | - | - | - | - | - | 9 | 10 | - | - | 10 | - | |||||
Warrants And Rights Outstanding | - | - | - | 13 | 0 | 0 | 0 | - | - | - | 0 | - | |||||
Derivative Liabilities Current | 1 | 1 | 7 | 1 | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 3 | 3 | 9 | 16 | 13 | 14 | 18 | 17 | 21 | 21 | 17 | 18 | |||||
Long Term Notes Payable | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | - | |||||
Defined Benefit Pension Plan Liabilities Noncurren… | - | - | - | - | 0 | 0 | 0 | 1 | 0 | 0 | 1 | - | |||||
Operating Lease Liability Noncurrent | 0 | 0 | 0 | - | - | - | - | 0 | 0 | 0 | 0 | - | |||||
Deferred Income Tax Liabilities Net | - | - | - | - | - | - | - | 3 | 3 | 3 | 3 | - | |||||
Liabilities | 3 | 3 | 9 | 16 | 13 | 14 | 19 | 21 | 24 | 25 | 22 | - | |||||
Temporary Equity Carrying Amount Attributable To P… | - | - | - | - | - | - | - | - | 64 | 64 | 64 | - | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 153 | 148 | 148 | 141 | 135 | 133 | 128 | 120 | 49 | 49 | 49 | 45 | |||||
Treasury Stock Common Value | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | - | - | - | - | |||||
Retained Earnings Accumulated Deficit | -138 | -135 | -131 | -137 | -128 | -125 | -116 | -86 | -82 | -68 | -57 | -34 | |||||
Treasury Stock Value | - | - | - | - | - | - | -1 | - | -1 | -1 | -1 | -1 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -1 | -0 | -0 | -1 | -0 | -3 | -3 | 1 | -2 | -2 | 2 | - | |||||
Minority Interest | - | - | - | - | - | - | - | 7 | 7 | 7 | 7 | - | |||||
Stockholders Equity | 13 | 12 | 16 | 3 | 6 | 4 | 9 | 34 | -36 | -14 | 1 | 10 | |||||
Liabilities And Stockholders Equity | 16 | 15 | 25 | 20 | 19 | 19 | 28 | 62 | 59 | 75 | 88 | 28 | |||||
Notes Payable | - | - | - | - | - | - | - | - | - | - | - | 1 | |||||
Preferred Stock Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Preferred Stock Shares Authorized | - | - | - | - | - | - | - | - | - | - | - | 10 | |||||
Preferred Stock Shares Issued | - | - | - | - | - | - | - | - | - | - | - | 0 | |||||
Deferred Finance Costs Current Net | - | - | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 250 | |||||
Common Stock Shares Issued | 4 | 3 | 2 | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Shares Outstanding | 4 | 3 | 2 | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -73.39% | -75.30% | -78.63% | - | - | - | - | - | - | - | - | - |
| 2025 | -26.07% | -45.15% | -53.42% | -10.03% | 0.97% | 9.71% | 5.53% | -34.02% | -41.80% | -44.01% | -76.61% | -95.58% |
| 2024 | -10.69% | -3.77% | -13.21% | -38.81% | 9.14% | -76.31% | 26.37% | -15.13% | -61.47% | -28.97% | -38.97% | -56.32% |
| 2023 | - | - | - | -22.09% | -39.32% | -55.34% | -26.25% | -45.72% | -48.67% | -20.51% | 32.05% | 7.05% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.21 | 1.41 | 0.66 | 0.08 | 0.07 | 0.17 | 0.05 | 0.06 | 0.10 | 0.29 | 0.34 | 0.54 | |||||
| Quick Ratio | 2.02 | 1.23 | 0.61 | 0.05 | 0.02 | 0.11 | 0.04 | 0.03 | 0.05 | 0.22 | 0.27 | 0.43 | |||||
| Working Capital | 3.57M | 1.26M | -3.07M | -15.00M | -11.76M | -11.62M | -17.34M | -16.31M | -18.57M | -15.14M | -11.35M | -8.10M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.22 | 0.26 | 0.58 | 4.83 | 2.16 | 3.57 | 2.17 | 0.62 | -0.67 | -1.74 | 15.58 | 1.72 | |||||
| Interest Coverage TTM | -52.44 | -29.29 | -23.78 | -45.93 | -54.56 | -74.17 | -72.13 | -68.31 | -61.08 | -49.37 | -53.65 | -35.67 | |||||
| Debt Ratio | 0.18 | 0.21 | 0.37 | 0.83 | 0.67 | 0.76 | 0.66 | 0.34 | 0.40 | 0.34 | 0.25 | 0.63 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.03 | 0.01 | 0.00 | 0.00 | |||||
| Days Sales Outstanding TTM | 4.10 | 14.90 | 72.20 | 15.00 | 25.23 | 25.51 | 12.69 | 19.75 | 44.50 | 131.73 | - | - | |||||
| Receivables Turnover TTM | 89.04 | 24.50 | 5.06 | 24.33 | 14.47 | 14.31 | 28.77 | 18.49 | 8.20 | 2.77 | 0.00 | - | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -4.55 | -15.96 | -16.56 | -36.18 | -4,042.02 | -1,344.75 | -1,823.39 | -3,358.29 | -406,886.15 | -4,125.20 | -4,372.49 | -2,097.20 | |||||
| Free Cash Flow Per Share TTM | -4.54 | -15.59 | -10.32 | -3.92 | -306.59 | -170.44 | -325.82 | -905.55 | -121,460.39 | -1,305.72 | -1,593.80 | -1,383.92 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 80.40% | 79.63% | 77.62% | 85.41% | 66.45% | 47.37% | 41.80% | - | - | - | - | - | |||||
| Operating Profit Margin TTM | -2,525.02% | -2,109.88% | -2,190.03% | -3,736.17% | -3,489.03% | -3,011.33% | -2,237.96% | -2,725.59% | -3,645.80% | -6,320.14% | - | - | |||||
| Net Profit Margin TTM | -1,578.79% | -1,364.24% | -1,904.77% | -4,154.88% | -3,458.21% | -2,986.26% | -2,333.39% | -2,847.66% | -3,780.24% | -6,521.91% | - | - | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -51.33% | -61.81% | -67.70% | -32.47% | -5.57% | 174.87% | - | - | - | - | - | - | |||||
| Net Income Growth (1Y) | -77.78% | -82.56% | -73.63% | -1.47% | -13.62% | 25.86% | 57.44% | 180.86% | 214.47% | 219.63% | 176.78% | - | |||||
| EPS Growth (1Y) | -99.89% | -98.81% | -99.09% | -98.92% | -99.01% | -67.40% | -58.30% | 60.13% | 19,056.69% | 129.61% | 98.49% | - | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.25 | -0.93 | -4.71 | -4.30 | -0.06 | -0.25 | -1.47 | -6.58 | -0.07 | -6.35 | -7.70 | -41.50 | |||||
| P/B TTM | 0.19 | 0.80 | 4.64 | 64.77 | 0.46 | 3.55 | 10.12 | 10.01 | -0.10 | -20.00 | 205.05 | 74.49 | |||||
| P/S TTM | 3.92 | 12.74 | 89.70 | 178.59 | 2.04 | 7.36 | 34.26 | 187.40 | 2.64 | 413.90 | - | - | |||||
| Market Cap | 2.53M | 9.37M | 73.14M | 218.55M | 2.71M | 14.17M | 86.49M | 339.59M | 3.71M | 289.91M | 287.98M | 762.54M | |||||
| Enterprise Value | -3.26M | 5.90M | 70.62M | 217.87M | 11.16M | 21.55M | 95.17M | 339.37M | 12.98M | 295.97M | 293.17M | 768.37M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -10.19M | -9.80M | -9.68M | -5.51M | -3.48M | -7.29M | -10.52M | -13.91M | -15.86M | -14.46M | -13.64M | -12.12M | |||||
| Net Debt | -5.79M | -3.47M | -2.52M | -676.29K | 8.45M | 7.38M | 8.68M | -223.05K | 9.27M | 6.05M | 5.18M | 5.84M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Onconetix, Inc. (ONCO) — SEC Financial Statements & Analysis
Onconetix, Inc. (ONCO) is a pharmaceutical preparations company, incorporated in DE. Onconetix, Inc. trades on Nasdaq as: ONCO. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Onconetix, Inc. reported a -51.33% year-over-year revenue growth, a Gross Profit Margin of 80.40% (TTM), a Debt-to-Equity ratio of 0.22x, a Price-to-Sales (P/S) ratio of 3.92x (TTM), a Price-to-Book (P/B) ratio of 0.19x (TTM), at a market cap of $2.53M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -51.33%
- Gross Profit Margin TTM
- 80.40%
- Debt To Equity
- 0.22x
- P/S TTM
- 3.92x
- P/B TTM
- 0.19x
- Market Cap
- $2.53M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Onconetix, Inc. in?
Onconetix, Inc. (ONCO) operates in the Pharmaceutical Preparations industry.
What is ONCO's market cap?
Onconetix, Inc. (ONCO) has a market capitalization of $2.53M as of 2026-06-30.
What exchange does ONCO trade on?
Onconetix, Inc. (ONCO) trades on the Nasdaq.
Where is Onconetix, Inc. incorporated?
Onconetix, Inc. is incorporated in DE.